BNTC - CIK 0001808898
Benitec Biopharma Inc. trades as BNTC. This page tracks Benitec Biopharma Inc. through 309 SEC filings, with financial statements and metrics updated as new reports are filed.
Net profit margin compressed from 21.4% to -26082.7% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Quarterly report | 10-Q | 2026-05-14 |
| Major company event | 8-K | 2026-05-14 |
| Annual report (amended) | 10-K/A | 2026-03-20 |
| Major company event | 8-K | 2026-02-12 |
| Quarterly report | 10-Q | 2026-02-12 |
| 424B3 | - | 2026-02-11 |
| EFFECT | - | 2026-02-10 |
| Company correspondence | CORRESP | 2026-02-06 |
The largest companies sharing Benitec Biopharma Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year Benitec Biopharma Inc. reported a net loss of $37.92M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.